Latest News

• share
• favorite_border

Johnson & Johnson today launched the Dr. Paul Janssen Project – a multi-faceted public engagement initiative that extends the legacy of Dr. Paul Janssen – one of the most accomplished industry researchers and humanitarians of the 20th century – and promotes broader engagement and appreciation for the value that science and technology innovation brings to humanity.

• share
• favorite_border

Johnson & Johnson Launches Campaign for Champions of Science

• share
• favorite_border

Leading soy experts agree that including soyfoods in a balanced diet will have beneficial effects and improve nutrient intake among the U.S. population.

• share
• favorite_border

Amgen and Wyeth Pharmaceuticals today announced that data from a multicenter, randomized, double-blind trial of ENBREL plus methotrexate showed that 50 percent of patients with active early rheumatoid arthritis achieved clinical remission at one year.

• share
• favorite_border

Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the presentation of additional data that showed that the safety profile of ENBREL® (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy.

• share
• favorite_border

The National Psoriasis Foundation and Amgen released data which show that nearly 40 percent of patients with chronic moderate to severe psoriasis are not currently receiving any treatment. Further, more than half of moderate to severe patients on treatment are not being treated in accordance with AAD guidelines, which state that patients diagnosed with chronic moderate to severe plaque psoriasis are candidates for phototherapy or systemic therapy, including biologic agents.

• share
• favorite_border

Katie Lee Joel, the first season host of Bravo's hit, "Top Chef" and Shire Pharmaceuticals today announced Katie's participation in the company's Kidney Friendly Comfort Foods program, including her contribution of six recipes for the 2006 edition of the Kidney Friendly Comfort Foods: A Collection of Recipes for People with Chronic Kidney Disease.

• share
• favorite_border

Conversion to the non-calcium phosphate binder FOSRENOL(R) (lanthanum carbonate) from other phosphate binder therapies provides continued phosphorus control for end-stage renal disease patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication, according to data presented at the National Kidney Foundation's 2006 meeting.

• share
• favorite_border

The U.S. FDA has approved a new, higher dose formulation of the chewable non-calcium phosphate binder FOSRENOL® (lanthanum carbonate). The new, higher dose strengths of 750 milligrams (mg) and 1.0 gram (g) will be available in the U.S. by year end.

• share
• favorite_border

Shire Pharmaceuticals Group plc announces long-term treatment with FOSRENOL (R), a new non-calcium, non-aluminum phosphate binder, does not promote bone softening or cause harmful effects on bone, according to data.

• share
• favorite_border

Shire Pharmaceuticals announces that the FDA has approved FOSRENOL (R), a non-calcium, non-aluminum phosphate binder that reduces high phosphorus levels in end-stage renal disease patients.

• share
• favorite_border

An important discussion about reporting on the complex world of vaccines, especially timely with last week's news of the influenza vaccine shortage.

• share
• favorite_border

Amgen Inc. announced that at all doses studied, twice yearly injections of AMG 162, the company's investigational therapy for bone loss, significantly increased bone mineral density at the total hip compared with placebo at 12 months.

• share
• favorite_border

A nationwide survey shows that most respondents did not know that high cholesterol comes from two sources, even though they have high cholesterol. When asked about cholesterol sources, more than 77 percent stated incorrectly that the food they eat contributes the most to high cholesterol.

• share
• favorite_border

Amgen and Wyeth Pharmaceuticals announced that Enbrel (etanercept) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

• share
• favorite_border

FDA has granted marketing approval for Climara Pro (estradiol/levonorgestrel) transdermal system. Climara Pro, a thin, translucent patch, is the first once-a-week, combined hormone therapy for the relief of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats.

• share
• favorite_border

Baxter Healthcare Corporation announced today that the FDA approved ADVATE (Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method) rAHF-PFM for the prevention and control of bleeding episodes in people with hemophilia A.

• share
• favorite_border

Amgen and Wyeth Pharmaceuticals announced that patients in a second phase 3 clinical study assessing the efficacy and tolerability of Enbrel in the treatment of moderate to severe plaque psoriasis experienced significant and rapid improvement in their symptoms.

• share
• favorite_border

Amgen and Wyeth Pharmaceuticals announce that patients in a phase 3 clinical study assessing the efficacy and tolerability of Enbrel in the treatment of active ankylosing spondylitis experienced significant and rapid reduction in back pain and morning stiffness, and improvement in spinal mobility and physical function.

• share
• favorite_border

Amgen and Wyeth Pharmaceuticals announce that patients receiving Enbrel (R) 50 mg once weekly for the treatment of active rheumatoid arthritis experienced significant improvements in function and pain.

• share
• favorite_border

Amgen and Wyeth Pharmaceuticals announced Enbrel (R) in combination with methotrexate or alone had a more significant impact on the progression of structural damage in rheumatoid arthritis patients versus methotrexate alone.

• share
• favorite_border

Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces that its candidate phosphate binder, FOSRENOLË™ (lanthanum carbonate) for use in end-stage renal disease (ESRD) patients, has become the first non-calcium phosphate binder to demonstrate sustained efficacy and a good safety profile during three years of treatment, according to new data presented today at the World Congress of Nephrology.

• share
• favorite_border

Shire Pharmaceuticals Group plc announced that continued, long-term treatment with FOSRENOL (tm) maintains decreased levels of phosphate, which frequently escalate in end-stage renal disease patients.

• share
• favorite_border

Shire Pharmaceuticals Group plc has received an approvable letter from the U.S Food & Drug Administration for FOSRENOL(r) (lanthanum carbonate). FOSRENOL is a treatment for high phosphate levels in the blood, which occur in patients undergoing dialysis as a result of chronic kidney failure.

• share
• favorite_border

Watson Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration approved OXYTROL(tm), the first and only transdermal therapy to treat overactive bladder, with symptoms of urge urinary incontinence, urgency and frequency.

• share
• favorite_border

The vast majority of drug abuse deaths involving oxycodone are related to the ingestion of multiple drugs, not solely oxycodone, according to an analysis of over 1,000 deaths.

• share
• favorite_border

Wyeth (NYSE:WYE) announced today that the U.S. Food and Drug Administration approved EFFEXOR(r) XR (venlafaxine HCl) for the treatment of patients with social anxiety disorder (SAD), which may affect up to 13 percent of Americans at some point in their lives.

• share
• favorite_border

Nearly four decades of research conclude that power toothbrushes with rotation oscillation action, such as the Oral-B 3D Excel, are demonstrably more effective in removing plaque and reducing gingivitis than other types of power toothbrushes.

• share
• favorite_border

More than ever, a significant number of Americans resolved to ring in a smoke-free New Year when the clock struck midnight on December 31st. Leading economic researchers say this surge can be attributed to two key factors: cigarette price hikes and smoking ban legislation, which have taken hold in numerous states across the country.

• share
• favorite_border

Up to $2.3 billion in total health care cost savings and prevention of about 35,000 end-stage kidney disease cases could be achieved in just three years if Americans with type 2 diabetes and kidney disease received treatment with the angiotensin II receptor blocker irbesartan, according to an economic analysis of the international Irbesartan Diabetic Nephropathy Trial.

• share
• favorite_border

The U.S. Food and Drug Administration today approved the Commit Lozenge -- the first and only nicotine lozenge -- for over-the-counter sale. The Commit Lozenge, from the marketers of Nicorette, helps control cravings by delivering craving-fighting medicine fast.

• share
• favorite_border

Bristol-Myers Squibb Company and Sanofi-Synthelabo, Inc. announce that the U.S. Food and Drug Administration approved Avapro (R) (irbesartan) for the treatment of diabetic nephropathy in people with hypertension and type 2 diabetes.

• share
• favorite_border

Novolin InnoLet human insulin (rDNA origin) is designed to overcome the barriers to accurate dosing that are commonly associated with the vial and syringe method of insulin delivery, currently used by the majority of people in the United States taking insulin.

• share
• favorite_border

More than 10 million children (one in four) in the United States will go back to school this fall with an undetected vision problem that can interfere with learning. Despite this disturbing figure, a survey released by the Vision Council of America found that only 6% of parents recognize that vision problems can lead to difficulties in school.

• share
• favorite_border

Acorda Therapeutics has begun two phase 3 clinical studies to evaluate the safety and efficacy of its lead product, Fampridine-SR, in chronic spinal cord injury patients. The trials examine the drug's ability to treat moderate-to-severe spasticity, which affects up to 75 percent of SCI patients.

• share
• favorite_border

People with social anxiety disorder (SAD), also known as social phobia, significantly reduced their fear, anxiety and related symptoms in four or six weeks of treatment with the extended release (XR) formulation of the antidepressant venlafaxine, the first available serotonin-norepinephrine reuptake inhibitor (SNRI), according to data from two studies.

• share
• favorite_border

New mothers have unique yet unmet contraceptive needs, which may have personal and societal consequences, according to a new national survey by Emory University School of Medicine. Nearly half of new and expectant mothers are using or considering a different birth control method than they used prior to becoming pregnant.

• share
• favorite_border

Nicotine replacement therapies, such as a skin patch or gum, when used by smokers on their own as over-the-counter medicines, safely yield smoking cessation success rates as good as when administered under a physician's prescription.

• share
• favorite_border

According to a recent survey conducted by Vision Council of America, nearly half of parents reported that their children "seldom" or "never" wear sunglasses with 100% UV protection.

• share
• favorite_border

The ability to fully engage in and enjoy family, personal and community activities is a critical milestone on the way to overcoming depression, according to the first survey to define treatment success through the eyes of people with depression.

• share
• favorite_border

At the start of National Volunteer Week, Delta Burke, two-time Emmy Award nominated actress and long-time depression sufferer, announced a national awareness campaign called "GOAL! Go On And Live."

• share
• favorite_border

A recent UC/Berkeley study found that as many as 30% of US children cause undue stress on their visual systems by overusing their computers. The study also shows a strong correlation between lengthy computer use and premature myopia (nearsightedness).

• share
• favorite_border

Nearly 70 percent of children begin receiving dental care two years later than the age recommended by pediatric dental experts, according to a survey by Gallup & Robinson.

• share
• favorite_border

Since nicotine replacement therapy became available as a nonprescription treatment to help Americans stop smoking, the number of adults attempting to quit smoking significantly increased to nearly 40 percent, according to a study of U.S. census data scheduled for presentation on Friday, Feb. 22, 2002 at the Eighth Annual Society for Research on Nicotine and Tobacco in Savannah, Ga.

• share
• favorite_border

A single injection of a first-of-its-kind experimental vaccine, Nabi StaphVAX, reduced bloodstream infections caused by the often drug-resistant and potentially deadly bacteria, Staphylococcus aureus, in end-stage kidney disease patients by nearly 60 percent, according to a Phase III study.

• share
• favorite_border

While American women continue to pay attention to and feel the impact of September 11, they are strong, knowledgeable and pragmatic, according to a new national survey by the Center for Gender Equality. A majority of women indicated they are not changing their lives, but their concerns about economic vulnerability and health care are greater than those related to their personal safety.

• share
• favorite_border

While American women continue to pay attention to and feel the impact of September 11, they are strong, knowledgeable and pragmatic, according to a new national survey by the Center for Gender Equality. A majority of women indicated they are not changing their lives, but their concerns about economic vulnerability and health care are greater than those related to their personal safety.

• share
• favorite_border

Eighty percent of a child's learning is obtained through vision, yet 25 percent of grade schoolers have vision deficiencies. The Vision Council of America (VCA) is releasing survey results on Americans' views on requiring mandatory comprehensive eye exams before a child's first year of school.

• share
• favorite_border

The quality of care for women with high blood pressure falls considerably short of the standards set by a panel of medical experts, according to a RAND report in Archives of Internal Medicine. The study found that the average woman with high blood pressure receives less than two thirds of the essential, scientifically validated care processes she needs.

• share
• favorite_border

Berlex Laboratories, Inc. announced the FDA approved YASMIN(r), a new, low-dose, monophasic oral contraceptive, which is the first and only to contain the unique progestin, drospirenone. Drospirenone influences water and electrolyte balance.